Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more


(Plasmid #60026)


Item Catalog # Description Quantity Price (USD)
Plasmid 60026 Standard format: Plasmid sent in bacteria as agar stab 1 $85

This material is available to academics and nonprofits only.


  • Vector backbone
  • Backbone manufacturer
  • Total vector size (bp) 6000
  • Modifications to backbone
    insertion of TALE DNA binding domain via Golden gate cloning containing following RVDs: NN-HD-HD-HD-NI-NN-NI-NI-NN-NI-HD-NG-HD-HD-HD-NN-HD
  • Vector type
    Mammalian Expression, TALEN

Growth in Bacteria

  • Bacterial Resistance(s)
    Ampicillin, 100 μg/mL
  • Growth Temperature
  • Growth Strain(s)
    XL1 Blue
  • Copy number


  • Gene/Insert name

Resource Information

Terms and Licenses

  • Academic/Nonprofit Terms
  • Industry Terms
    • Not Available to Industry
  • Zeocin® is an InvivoGen trademark.
How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    TALEN-mROSA26 ELD was a gift from Radislav Sedláček (Addgene plasmid # 60026 ; ; RRID:Addgene_60026)
  • For your References section:

    Efficient gene targeting of the Rosa26 locus in mouse zygotes using TALE nucleases. Kasparek P, Krausova M, Haneckova R, Kriz V, Zbodakova O, Korinek V, Sedlacek R. FEBS Lett. 2014 Sep 18. pii: S0014-5793(14)00689-9. doi: 10.1016/j.febslet.2014.09.014. 10.1016/j.febslet.2014.09.014 PubMed 25241166